Advertisement

Topics

Companies Related to "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" [Most Relevant Company Matches] - Page: 2 RSS

16:42 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" found in our extensive corporate database of over 50,000 company records.

Showing "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated" Companies 26–50 of 3,700+

Relevant

PharmaMar USA

PharmaMar was founded in 1986, as part of the Zeltia group, with the vision of exploiting the great potential of the oceans as a source of novel medicines for improved cancer treatment. PharmaMar headquarters are located in Madrid (Spain) with additional laboratories located in Cambridge (Massachusetts). PharmaMar has become a leading company in the field of marine anticancer drugs, with six novel...


Genexine Inc.

Genexine, Inc, listed on KOSDAQ (095700-KQ) since 2009, is a clinical stage biotherapeutics company focused on immuno-oncology,metabolic and autoimmune diseases. Genexine has robust R&D pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA vaccine technology. In the clinical stage, Genexine has GX-H9 (l...

Genexine, Inc.

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH...


EPIX Pharmaceuticals

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products through the use of proprietary technology to better diagnose, treat and manage patients. The company has five internally-discovered therapeutic and imaging drug candidates currently in clinical trials targeting conditions such as depression, Alzheimer's disease, ...

Triphase

Triphase is a private, oncology- focused accelerator dedicated to advancing compelling, well differentiated drugs through human proof of concept (Phase II) faster and more efficiently than the pharmaceutical and biotech industry. Triphase has unique strategic relationships with Celgene and the Ontario Institute for Cancer Research (OICR). The company is le...

Ziarco Pharma Ltd.

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting dermatological and inflammatory diseases. ZPL-389, the Company’s lead compound, is an oral histamine H4 receptor antagonist, currently in two Phase 2a studies: the first in atopic dermatitis is fully recruited and will read out in Q2 2016; and the second has ...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly re...

CMAXA division of
Institute of Drug Technology (IDT) Australia Ltd

CMAX’s clinical research and analytical facility is committed to providing excellence and quality when servicing the needs of pharmaceutical manufacturers and researchers worldwide. CMAX is located in Adelaide, South Australia, and offers a wide range of services for the design, implementation and management of Phase I - IV clinical studies.The self contained clinical unit has a 48 bed capacity ...

Amazentis SA

Amazentis SA is a life science company that employs today’s leading research and clinical science to develop the next generation of bioactive ingredients derived from nature for advanced therapeutic nutrition products. The Company’s lead product candidate, AMAZ-02, an oral formulation of Urolithin A, is planned to enter Phase 2 clinical testing d...

American Society of Landscape Architects

Founded in 1899, the American Society of Landscape Architects (ASLA) is the national professional association for landscape architects, representing more than 15,000 members in 49 professional chapters and 76 student chapters. The Society's mission is to lead, to educate and to participate in the careful stewardship, wise planning and artful design of our ...

Phase Forward Europe Limited

Phase Forward Incorporated, the leading provider of clinical informatics for drug development, is dedicated to helping pharmaceutical, biotechnology and medical device companies bring needed drugs and therapies to market faster. The company offers proven solutions in electronic data capture (EDC), clinical data management (CDM), electronic patient diary, and adverse event reporting (AER) as either...

Etreby Computer Company, Inc.

Etreby Computer Company has a long-standing commitment to serve the technology needs of healthcare professionals. For more than two decades, Etreby has been providing the finest software solutions to pharmacy professionals nationwide.Community pharmacists has always relied on Etreby to provide technologically advanced, user-friendly software systems, that efficiently improve workflow, increase pro...

Medscape, LLC

Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.Most specialty sites are organized consistently so you'll know where to find your favorite features as you move from specialty to specialty. Ea...

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “ge...

Invicro LLC

Based in Boston, MA, Invicro was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeutic areas. Invicro’s multi-disciplinary team provides a full range of image informatics, engineering and operational services. Originally focused on imaging in discovery phas...

Javelin Pharmaceuticals, Inc.

With corporate headquarters in Cambridge, MA, Javelin applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs to target unmet and underserved medical needs in the pain management market. The company has one marketed drug in the U.K., an NDA-submitted drug candidate, Dyloject™, and two drug candidates in ...

Biofrontera AG

Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in clinical development for four different clinical indications. The most advanced products are BF-200 ALA (Phase IIb/III) for actinic keratosis and condyloma; and BF-derm 1 (Phase II) for chronic, antihistami...

ReadCoor, Inc.

ReadCoor is leading the next generation of omics by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with Fluorescent In-Situ Sequencing (FISSEQ), a fundamental new technology, which simultaneously integrates high t...

DIATOS S.A

Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and dru...

Kun Run Biotechnology, Inc.

Kun Run Biotechnology, Inc., together with its subsidiaries, engages in the manufacture and sale of polypeptide medicines and small molecule drugs. It uses solid phase peptide synthesis (SPPS) and advanced purifying technology to produce various therapeutic polypeptide drugs, of which "TP-5" is the most known for efficiently regulating humans' immune systems in order to defend and cure maligna...

Phase One Medical, L.L.C.

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage development and small part design and manufacture. For more information on Phase One Medical, L.L.C. products and services e-mail the company at info@phase-one.us.

The Center for Biosimilars

The Center for Biosimilars® is a digital resource that serves as a platform for health economic experts, managed care professionals, key clinical specialists and other authoritative industry voices, to share information on emerging technologies, with a focus on improving critical thinking in the field to affect patient outcomes. The Center for Bi...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...

The Hood Incubator

The Hood Incubator was founded in 2016 to build political and economic power for Black and Brown communities in the rapidly growing cannabis industry. The nonprofit organization fulfils its mission of increasing the participation of Black and Brown communities in the legal cannabis industry through three main areas of work: Community Organizing, Policy Adv...

MacroMed Inc.

Founded in 1995, MacroMed is a privately-held company developing and manufacturing advanced proprietary biodegradable injectable and oral polymeric drug delivery systems for internal products and products in partnership with pharmaceutical and biotech companies. The Company's platform of technologies is ideal for: enhancing the safety and efficacy of active agents; enabling formulation of insolubl...


More From BioPortfolio on "SeborrheaGlobal Manufacturers Marketed Phase Drugs Landscape 2017 Updated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks